Portfolio

RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies. Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. 

Select to filter companies by category

Active Companies

Arch Oncology, Inc.
Archmont Biopharma, Inc.
Avalyn Pharma, Inc.
Cardialen, Inc.
Good Therapeutics, Inc.
Glycomine, Inc.
InterVene, Inc.
Neuros Medical, Inc.
OncoResponse, Inc.
OxaluRx, Inc.
Scout Bio, Inc.
SeQure Dx
Sparrow Pharmaceuticals
Standard Bariatrics, Inc.
VentureMed Group, Inc.
Wugen, Inc.
Xilio Therapeutics

Exited Companies

Allakos, Inc.
Amplyx Pharmaceuticals, Inc.
Cabrellis Pharmaceuticals Corporation
Cameron Health, Inc.
Centerre Healthcare Corporation
CGI Pharmaceuticals Inc.
Conforma Therapeutics Corporation
Curzion Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc.
IDEV Technologies, Inc.
Lumena Pharmaceuticals, Inc.
Lutonix, Inc.
MacroGenics, Inc.
Mirum Pharmaceuticals, Inc.
Mpex Pharmaceuticals, Inc.
Otonomy, Inc.
Reneo Pharmaceuticals, Inc.
Salient Surgical Technologies, Inc.
Securus Medical Group, Inc.
Spruce Biosciences, Inc.
Velocimed, LLC
ZS Pharma Inc.
Map
MapMapMapMapMapMap
RiverVest’s Footprint Increases Its Opportunity Set

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Learn More